QMSR for MedTech Startups: What Changed for Design Controls in 2026
QMSR took effect February 2, 2026, and FDA now reads design controls through ISO 13485 and a risk-first inspection model. Here is a seven-point checklist MedTech startups can use to get design controls QMSR-ready.
Medical Device Commercialization Readiness: What Investors Expect in 2026
Medtech venture capital in 2026 is flowing to de-risked programs. Here are seven commercialization readiness questions medical device founders should answer before the next raise, from design inputs and FDA pathway to manufacturability.
Single-Use or Re-Sterilizable? The Product Decision That Is More Than Engineering
Choosing between a single-use and a reusable design is one of the earliest architecture decisions in medical device development, and it shapes patient safety, clinical workflow, cost, regulatory strategy and sustainability.
A Question for MedTech Founders: When Did You Start Thinking About Manufacturing?
A working prototype is not automatically a scalable product. Here is why medical device founders should think about tolerances, inspection, supply chain and automation long before production.
The Automation Advantage: Why Medical Devices Should Be Designed to Scale
Automation begins before production. The tolerance, part handling, assembly and inspection decisions made during design determine how easily a medical device can scale.
Speed Wins in MedTech: Why Disciplined Iteration Moves Devices Forward
In medical device development, the fastest teams are not the ones that rush. They prototype to learn, set clear priorities and bring clinical and manufacturing input into every iteration.
The Hidden Costs of Medical Device Development
The most underestimated cost in medical device development is not engineering. It is the cascade of late design changes, and most of it can be prevented with earlier cross-functional planning.
Fractional Leadership for MedTech Startups
Many medical device startups do not need a full-time executive team yet, but they do need experienced program leadership. Here is what a fractional program leader does and when to bring one in.
How Design Reviews Prevent Expensive Downstream Problems
Costly medical device problems usually start as small gaps: an unclear requirement, an unrealistic tolerance, a missing test method. Strong cross-functional design reviews catch them early.
Why MedTech Innovation Matters
Behind every medical device in a clinic or operating room is a long journey from unmet need to commercial product. Here is what that journey involves and why execution matters as much as the idea.
Smart Manufacturing: How to Prepare Your Medical Device Line for the Factory of the Future
A smart factory starts with planning, not robots. How medical device manufacturers can prepare with scalable line layouts, traceability data, modular automation and OEE from the beginning.
Why Program Leadership Matters in MedTech
Medical device programs juggle engineering, clinical, regulatory, quality, supplier and manufacturing workstreams at once. Strong program leadership is what keeps them aligned and moving.
When Should Medical Device Companies Start Thinking About Automation?
Most teams assume automation comes once volume grows. In reality, medical device automation strategy should begin during product design and process development, even if early production stays manual.
From Concept to First-in-Human: Building the Path to Clinical Validation
Reaching a first-in-human study is one of the biggest milestones in MedTech. Here is the typical path from concept through feasibility, preclinical work, regulatory documentation and clinical supply.
For Early-Stage MedTech Founders: What Should You Focus on Next?
Early-stage medical device founders face many urgent choices at once. A development roadmap across product, regulatory, clinical and manufacturing strategy shows what to tackle first.
The #1 Mistake MedTech Startups Make: Waiting Too Long to Plan for Manufacturing
Many medical device startups wait too long to plan for manufacturing. Here is how design for manufacturability, early supplier engagement and automation strategy close the prototype-to-production gap.